When we look at a term sheet, we see a single piece of an overall business strategy.
Our goal is to design a transaction, not just to monetize IP, but also to drive the growth of your entire business. We can help you in the following ways:
Start-up
License core technologies and obtain venture financing
Equity Financing by Foresite Capital, Google Ventures, Arch Ventures, Boyu Capital, Blue Pool Capital, Merck Ventures, and Alexandria Venture Investments
Sale of AuthAir, Inc., a portfolio company of .406 Ventures providing proximity-based security and wireless authentication solutions with real-time analytics to assist healthcare providers with compliance, regulation and business intelligence, to LogMeIn
Launch of New Venture Focused on Stem Cell Transplants to Treat Early-Stage Cancers and Autoimmune Diseases, Including Exclusive License from Harvard University
Strategic Research Collaboration to Develop Treatments for Metabolic Diseases Utilizing Proprietary Antisense and RNAi Technologies (including $40 million in upfront payments, up to $871 million in milestone payments, and royalties)
Gene Therapy Alliance with Weill Cornell Medical through a series of 3 exclusive license agreements and a services agreement for research, development and commercialization of multiple AAV-based gene therapy indications
Equity Financing by Foresite Capital, Google Ventures, Arch Ventures, Boyu Capital, Blue Pool Capital, Merck Ventures, and Alexandria Venture Investments
Sale of AuthAir, Inc., a portfolio company of .406 Ventures providing proximity-based security and wireless authentication solutions with real-time analytics to assist healthcare providers with compliance, regulation and business intelligence, to LogMeIn
